JP2019505185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505185A5 JP2019505185A5 JP2018531159A JP2018531159A JP2019505185A5 JP 2019505185 A5 JP2019505185 A5 JP 2019505185A5 JP 2018531159 A JP2018531159 A JP 2018531159A JP 2018531159 A JP2018531159 A JP 2018531159A JP 2019505185 A5 JP2019505185 A5 JP 2019505185A5
- Authority
- JP
- Japan
- Prior art keywords
- hmwk
- sample
- hae
- peptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022096962A JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562267734P | 2015-12-15 | 2015-12-15 | |
| US62/267,734 | 2015-12-15 | ||
| PCT/US2016/066936 WO2017106504A1 (en) | 2015-12-15 | 2016-12-15 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022096962A Division JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019505185A JP2019505185A (ja) | 2019-02-28 |
| JP2019505185A5 true JP2019505185A5 (cg-RX-API-DMAC7.html) | 2020-01-30 |
| JP7092669B2 JP7092669B2 (ja) | 2022-06-28 |
Family
ID=57794352
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531159A Active JP7092669B2 (ja) | 2015-12-15 | 2016-12-15 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2022096962A Active JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A Active JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022096962A Active JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A Active JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11668718B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4597115A3 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7092669B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102874711B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108602877A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2016372159B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3008621A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2018007216A2 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201891414A1 (cg-RX-API-DMAC7.html) |
| IL (4) | IL312919B1 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2018007493A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ743482A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017106504A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3060582B1 (en) | 2013-10-21 | 2020-09-23 | Dyax Corp. | Assays for determining plasma kallikrein system biomarkers |
| US10101344B2 (en) | 2013-10-21 | 2018-10-16 | Dyax Corp. | Diagnosis and treatment of autoimmune diseases |
| DK3365685T3 (da) | 2015-10-19 | 2021-03-01 | Dyax Corp | Immunoassay til påvisning af spaltet højmolekylært kininogen |
| EP4597115A3 (en) | 2015-12-15 | 2025-08-13 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
| EP3637106B1 (en) * | 2017-06-08 | 2023-03-22 | University of Miyazaki | Lung cancer detection method |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047323A (en) * | 1986-01-22 | 1991-09-10 | Temple University Of The Commonwealth System Of Higher Education | Method for detecting human kininogen using monoclonal antibodies thereto |
| JP2603487B2 (ja) | 1987-11-26 | 1997-04-23 | 大日本製薬株式会社 | ガンに罹患している疑いのあるヒトをスクリーニングする方法 |
| JPH08208692A (ja) | 1994-09-28 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | 新規な細胞接着抑制ペプチド誘導体 |
| JP3073439B2 (ja) * | 1996-02-08 | 2000-08-07 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| WO2000027415A2 (en) | 1998-11-10 | 2000-05-18 | Temple University - Of The Commonwealth System Of Higher Education | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5 |
| US20060154319A1 (en) | 1999-04-29 | 2006-07-13 | Flodgaard Hans J | Inhibition of bradykinin release |
| AU1761601A (en) | 1999-11-12 | 2001-06-06 | Bristol-Myers Squibb Pharma Company | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain |
| JP2006501139A (ja) | 2002-03-15 | 2006-01-12 | アテニュオン， エルエルシー | 血管形成阻害の標的としての細胞表面トロポミオシン |
| CN1858243A (zh) | 2005-04-30 | 2006-11-08 | 安徽省生物医学研究所 | 一种预测血管紧张素ii受体拮抗剂类降压药药物作用的方法及其应用 |
| WO2009051259A1 (ja) | 2007-10-18 | 2009-04-23 | Miyazaki Prefectural Industrial Support Foundation | 肝疾患診断用バイオマーカー |
| US20110160434A1 (en) | 2008-07-07 | 2011-06-30 | Nippon Zoki Pharmaceutical Co., Ltd. | Fibromyalgia test method |
| GB0821721D0 (en) | 2008-11-27 | 2008-12-31 | Hansa Medical Ab | Antimicrobial therapy |
| DK3173792T3 (da) | 2009-03-30 | 2019-08-05 | Novartis Ag | Crp neo-epitop fibrose-assay |
| JP5714285B2 (ja) | 2010-09-29 | 2015-05-07 | 株式会社プロトセラ | 妊娠高血圧症候群マーカーおよびそれを用いた診断 |
| CN102558329A (zh) | 2010-12-10 | 2012-07-11 | 中国人民解放军军事医学科学院生物医学分析中心 | 一组特异性多肽及其在制备肺癌早期诊断试剂中的用途 |
| PL2831113T3 (pl) | 2012-03-28 | 2018-08-31 | Sanofi | Przeciwciała przeciwko ligandom receptora bradykininy B1 |
| SMT201800563T1 (it) * | 2013-01-20 | 2018-11-09 | Dyax Corp | Valutazione e trattamento di disturbi mediati da bradichinina |
| JP2016188761A (ja) | 2013-08-23 | 2016-11-04 | 国立研究開発法人国立国際医療研究センター | 糖尿病腎症の発症または発症リスクの検出方法及びキット |
| EP3060582B1 (en) * | 2013-10-21 | 2020-09-23 | Dyax Corp. | Assays for determining plasma kallikrein system biomarkers |
| US10281473B2 (en) * | 2014-02-04 | 2019-05-07 | University Of Virginia Patent Foundation | Compositions and methods for analysis of protein sequences and post-translational modifications |
| CN104345154B (zh) | 2014-08-22 | 2016-10-26 | 北京蛋白质组研究中心 | 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒 |
| CN104155457B (zh) | 2014-08-22 | 2016-11-16 | 北京蛋白质组研究中心 | 一种结直肠癌相关“多肽-蛋白组合式标志物”检测试剂盒 |
| US10295550B2 (en) * | 2014-11-17 | 2019-05-21 | The Rockefeller University | Compositions and methods for use in diagnosis of alzheimer's disease |
| EP4597115A3 (en) | 2015-12-15 | 2025-08-13 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
-
2016
- 2016-12-15 EP EP25162494.6A patent/EP4597115A3/en active Pending
- 2016-12-15 NZ NZ743482A patent/NZ743482A/en unknown
- 2016-12-15 AU AU2016372159A patent/AU2016372159B2/en active Active
- 2016-12-15 IL IL312919A patent/IL312919B1/en unknown
- 2016-12-15 WO PCT/US2016/066936 patent/WO2017106504A1/en not_active Ceased
- 2016-12-15 CN CN201680079865.9A patent/CN108602877A/zh active Pending
- 2016-12-15 US US16/062,734 patent/US11668718B2/en active Active
- 2016-12-15 IL IL322971A patent/IL322971A/en unknown
- 2016-12-15 EA EA201891414A patent/EA201891414A1/ru unknown
- 2016-12-15 EP EP16825947.1A patent/EP3390439B1/en active Active
- 2016-12-15 JP JP2018531159A patent/JP7092669B2/ja active Active
- 2016-12-15 KR KR1020247036874A patent/KR102874711B1/ko active Active
- 2016-12-15 KR KR1020187020049A patent/KR102728491B1/ko active Active
- 2016-12-15 CO CONC2018/0007216A patent/CO2018007216A2/es unknown
- 2016-12-15 IL IL297850A patent/IL297850B2/en unknown
- 2016-12-15 MX MX2018007493A patent/MX2018007493A/es unknown
- 2016-12-15 CA CA3008621A patent/CA3008621A1/en active Pending
-
2018
- 2018-06-13 IL IL259995A patent/IL259995B2/en unknown
- 2018-06-15 MX MX2023000773A patent/MX2023000773A/es unknown
-
2022
- 2022-06-10 AU AU2022204058A patent/AU2022204058B2/en active Active
- 2022-06-16 JP JP2022096962A patent/JP7425117B2/ja active Active
-
2023
- 2023-04-28 US US18/308,813 patent/US12135329B2/en active Active
-
2024
- 2024-01-18 JP JP2024005910A patent/JP7758766B2/ja active Active
- 2024-09-24 US US18/894,192 patent/US20250172567A1/en active Pending
-
2025
- 2025-01-22 AU AU2025200412A patent/AU2025200412A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019505185A5 (cg-RX-API-DMAC7.html) | ||
| Tammen et al. | Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display | |
| Peyvandi et al. | Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity | |
| Rehak et al. | The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors | |
| JP4505045B2 (ja) | 血液凝固時間の延長原因の判定法 | |
| Caires et al. | Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis | |
| JP2016536012A5 (cg-RX-API-DMAC7.html) | ||
| KR20090023369A (ko) | Ｄ-다이머 및 가용성 피브린 수준 측정에 의한 혈전색전성 정맥 질환의 검출 | |
| US20250172567A1 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk | |
| JP2022141640A5 (cg-RX-API-DMAC7.html) | ||
| Aletti et al. | Peptidomic analysis of rat plasma: proteolysis in hemorrhagic shock | |
| da Silva Vaz Junior et al. | Changes in saliva protein profile throughout Rhipicephalus microplus blood feeding | |
| JP2024026847A5 (cg-RX-API-DMAC7.html) | ||
| EP2109688A2 (en) | Galectin-3-binding, protein as a biomarker of cardiovascular disease | |
| Sempere et al. | Assessing the short-and long-term prognosis of patients with cirrhosis and acute variceal bleeding | |
| Wosiewicz et al. | Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability | |
| Williams et al. | A bovine model of hypoxia-induced pulmonary hypertension reveals a gradient of immune and matrisome response with a complement signature found in circulation | |
| Liu et al. | Proteomic profiling of the midgut contents of Haemaphysalis flava | |
| EA034043B1 (ru) | Способ определения продуктов деградации пептидов из протеолитического каскада в образцах крови | |
| JP6907188B2 (ja) | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 | |
| Dubois et al. | Dipeptidyl peptidase 9 (DPP9) from bovine testes: Identification and characterization as the short form by mass spectrometry | |
| EP1920068A1 (en) | Lupus anticoagulant testing | |
| NZ783522B2 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| NZ783522A (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| JP2014531413A (ja) | 異物表面との接触による血液凝固系の活性化の熱安定性阻害剤 |